CEP290
Centrosomal protein of 290 kDa
As of the edition of 20 October 2026, CEP290 (centrosomal protein of 290 kDa, UniProt O15078) has 1 drug tested at it and 2 companies on the list, 1 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- O15078
- How well studied
- Biology documented; no tool compounds or approved drug yet
- Where it sits in the cell
- Inside the cell
- Disease areas
- Eye; Inherited and neonatal; Nervous system; Nutrition and metabolism
- Registered trials of its drugs
- 4
Drugs at this target
| Status | Count |
|---|---|
| Stopped | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Sepofarsen | Stopped | Phase 3 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 1 |
| Engaged | 1 |
| Total on the list | 2 |
| Company | Route |
|---|---|
| Laboratoires Thea | Route A |
The other 1 company at CEP290
In the product2 companies in all; 1 is not named here, and no score is.
See the 2 companies at CEP290, ranked, with the facts behind eachRequest access. Nothing is shown until you do.